CMV and T7 promoter expression plasmid for human codon optimized SpCas9 with a c-terminal bi-partite NLS, 3x flag tag, and P2A-EGFP

Gateway compatible destination vectors containing StrepIII/HA/BioID

AAV Soma-targeted Cal-Light with KA2

pLentiCRISPR that is selectable with puromycin with an sgRNA targeting TP53

SB-transposon with constitutive bi-directional promoter, one side: SfiI cloning site for GOI (contains filler DNA), other side: RFP and blasticidin resistance gene

C-terminal fusion to oxBFP

Expresses an mCherry-SopF fusion in mammalian cells

Standardized mini-Tn5 delivery plasmid, gentamicin resistant

Ready-to-use AAV1 particles produced from pAAV-CAG-fDIO-mNeonGreen (#99133). In addition to the viral particles, you will also receive purified pAAV-CAG-fDIO-mNeonGreen plasmid DNA. CAG-driven, Flp-dependent mNeonGreen expression. These AAV preparations are suitable purity for injection into animals.

dTAG for N-terminal tagging

Expression of Halo-Tag. Use as control for Halo-tag fusions

Expresses mCherry targeted to the outer mitochondrial membrane via the Fis1 tail anchor sequence

Version 2 of the human CRISPRa genome wide library

Ready-to-use AAV9 particles produced from pAAV-CAG-DIO-NLS-mRuby3-IRES-eGtACR1-ST (#109048). In addition to the viral particles, you will also receive purified pAAV-CAG-DIO-NLS-mRuby3-IRES-eGtACR1-ST plasmid DNA. Cre-dependent expression of the anion channelrhodopsin GtACR1 fused to ER export signal and targeted to the neuronal soma and proximal dendrites, translated from an internal ribosomal entry site (IRES) following mRuby3 expression. These AAV preparations are suitable purity for injection into animals.

Encodes SARS-CoV-2 variant XBB.1.5 Spike for pseudovirus production

4A8 variant in barcoded, yeast surface display plasmid